Lexicon Pharmaceuticals Inc (LXRX)
1.16
-0.04
(-3.73%)
USD |
NASDAQ |
Nov 05, 14:40
Lexicon Pharmaceuticals Price to Book Value: 1.747 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.815 |
| November 01, 2024 | 1.838 |
| October 31, 2024 | 2.937 |
| October 30, 2024 | 2.937 |
| October 29, 2024 | 3.058 |
| October 28, 2024 | 2.802 |
| October 25, 2024 | 2.711 |
| October 24, 2024 | 2.772 |
| October 23, 2024 | 2.802 |
| October 22, 2024 | 2.922 |
| October 21, 2024 | 2.937 |
| October 18, 2024 | 3.133 |
| October 17, 2024 | 3.028 |
| October 16, 2024 | 2.877 |
| October 15, 2024 | 2.696 |
| October 14, 2024 | 2.696 |
| October 11, 2024 | 2.621 |
| October 10, 2024 | 2.546 |
| October 09, 2024 | 2.455 |
| October 08, 2024 | 2.531 |
| October 07, 2024 | 2.531 |
| October 04, 2024 | 2.546 |
| October 03, 2024 | 2.425 |
| October 02, 2024 | 2.425 |
| October 01, 2024 | 2.38 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.365 |
| September 27, 2024 | 2.410 |
| September 26, 2024 | 2.320 |
| September 25, 2024 | 2.275 |
| September 24, 2024 | 2.365 |
| September 23, 2024 | 2.38 |
| September 20, 2024 | 2.500 |
| September 19, 2024 | 2.546 |
| September 18, 2024 | 2.470 |
| September 17, 2024 | 2.440 |
| September 16, 2024 | 2.455 |
| September 13, 2024 | 2.561 |
| September 12, 2024 | 2.516 |
| September 11, 2024 | 2.546 |
| September 10, 2024 | 2.516 |
| September 09, 2024 | 2.516 |
| September 06, 2024 | 2.425 |
| September 05, 2024 | 2.440 |
| September 04, 2024 | 2.455 |
| September 03, 2024 | 2.425 |
| August 30, 2024 | 2.606 |
| August 29, 2024 | 2.711 |
| August 28, 2024 | 2.591 |
| August 27, 2024 | 2.591 |
| August 26, 2024 | 2.666 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.313
Minimum
Apr 25 2024
9.417
Maximum
Feb 15 2024
3.846
Average
3.604
Median
Jan 12 2024
Price to Book Value Benchmarks
| Viatris Inc | 0.7087 |
| AIM ImmunoTech Inc | 2.567 |
| Perspective Therapeutics Inc | 2.387 |
| Protalix BioTherapeutics Inc | 3.294 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 83.34 |
| PEG Ratio | -0.1012 |
| Price | 1.16 |
| Earnings Yield | -67.24% |
| Market Cap | 419.33M |
| PEGY Ratio | -0.1012 |